Impact of nonexacerbated COPD on mortality in critically Ill patients

Chest

Volumn 139, Issue 6, 2011, Pages 1354-1360

  Rodríguez, Alejandro ^a   Lisboa, Thiago ^a   Solé Violán, Jorge ^b   Gómez, Federico ^a   Roca, Oriol ^c   Trefler, Sandra ^a   Gea, Joaquim ^d   Masclans, Joan R ^c   Rello, Jordi ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b Department of Radiation Oncology and Research Unit Dr Negrin University Hospital   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; FEMALE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; INTUBATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHOCK; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 79958706086     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2439     Document Type: Article

References (33)

1. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27(6):1210-1216. (Pubitemid 44914306)
2. Nevins ML, Epstein SK. Predictors of outcome for patients with COPD requiring invasive mechanical ventilation. Chest. 2001;119(6):1840-1849. (Pubitemid 32744944)
3. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest. 2000;117(3):662-671. (Pubitemid 30152203)
4. Rabe KF, Hurd S, Anzueto A, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
5. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245-1257. (Pubitemid 44883863)
6. Rodríguez A, Mendia A, Sirvent JM, et al; CAPUCI Study Group. Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock. Crit Care Med. 2007;35(6):1493-1498. (Pubitemid 46809312)
7. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707-710.
8. Bodí M, Rodríguez A, Solé-Violán J, et al; Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival . Clin Infect Dis. 2005;41(12):1709-1716. (Pubitemid 41759852)
9. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962-969.
10. Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220.
11. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327-1335. (Pubitemid 351468409)
12. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder VA, Ulrich C, Harink-De Weerd JE. Critical illness polyneuropathy in multiple organ dysfunction syndrome and weaning from the ventilator. Intensive Care Med. 1996;22(9):856-861. (Pubitemid 26340630)
13. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859- 2867.
14. Barreiro E, Peinado VI, Galdiz JB, et al; ENIGMA in COPD Project. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction . Am J Respir Crit Care Med. 2010;182(4):477-488.
15. Halpin DM. Systemic effects of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2007;1(1):75-84.
16. ENVIN-HELICS Study. ENVIN-HELICS Web site. http://hws.vhebron.net/envin- helics. Accessed September 1, 2010.
17. Sethi S. Infection as a comorbidity of COPD. Eur Respir J. 2010;35(6):1209-1215.
18. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(9):991-998.
19. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465-471. (Pubitemid 34879333)
20. Vincent JL, Bihari DJ, Suter PM, et al; EPIC International Advisory Committee. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA. 1995;274(8):639-644.
21. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA. 1996;275(11):866-869. (Pubitemid 26087224)
22. Timsit JF, Chevret S, Valcke J, et al. Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med. 1996;154(1):116-123. (Pubitemid 26255776)
23. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986;133(5):792-796. (Pubitemid 16116505)
24. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA. 1993;270(16):1965-1970.
25. Rello J, Ollendorf DA, Oster G, et al; VAP Outcomes Scien tific Advisory Group. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-2121. (Pubitemid 36051151)
26. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94(3):281-288. (Pubitemid 23074802)
27. Craig CP, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control. 1984;12(4):233-238. (Pubitemid 14037501)
28. Cunnion KM, Weber DJ, Broadhead WE, Hanson LC, Pieper CF, Rutala WA. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med. 1996;153(1):158-162. (Pubitemid 26026843)
29. Papazian L, Bregeon F, Thirion X, et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med. 1996;154(1):91-97. (Pubitemid 26255772)
30. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C; The Canadian Critical Trials Group. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med. 1999;159(4 pt 1):1249-1256. (Pubitemid 29202563)
31. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest. 2005;128(3):1650-1656. (Pubitemid 41324460)
32. Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MJ, Anzueto A. Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia. Eur Respir J. 2010;36(4):751-757.
33. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28(2):346-351. (Pubitemid 44914234)